Final Trades: WST, BIIB, SPY & MDT

07:06pm, Wednesday, 11'th Oct 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion.
EXTON, Pa. , Sept. 7, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pre
Building a well-rounded portfolio is crucial as you plan for financial stability in your retirement. Diversification is critical, ensuring your investments are spread across various sectors and asset
West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock.
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
West Pharmaceutical Services has seen a 60% rally in its stock price since December 2022, outperforming the S&P 500. Momentum in financials shows a decline in top line sales but strong growth in contr
The stock of West Pharmaceutical Services Inc ( WST , Financial) has seen a daily gain of 4.13% and a 3-month gain of 6.84%. With an Earnings Per Share (EPS) of 6.86, the question arises: Is the stock
EXTON, Pa. , Aug. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pres
West Pharmaceutical's (WST) second-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.
West Pharmaceutical Services (WST) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $2.47 per share a year ago
West Pharmaceutical's (WST) second-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom
The stock market has been on an absolute tear this year with the S&P 500 up 19% and the Nasdaq 100 up a whopping 42.6% YTD.
My portfolio based on the stock selection methodology of The Dow Jones US Dividend 100 Index has returned 21.72% since its inception 8.5 months ago. This deep dive analysis tested the contribution tha
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE